EUVIMEDEUVIMED entdecken
Crossref

Liver Transplantation in Primary Hyperoxaluria: A Single‐Center 10‐Year Experience

Zahra Beyzaei iD, Alireza Shamsaeefar, Kiana Ghatei, Kurosh Kazemi, Saman Nikeghbalian, Ali Bahador, Masoud Dehghani, Seyed-Ali Malekhosseini, Bita Geramizadeh iD

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Zahra Beyzaei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Liver Transplantation, Hyperoxaluria, Primary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary hyperoxalurias (PHs) are rare inborn errors of metabolism caused by a deficiency of hepatic enzymes, leading to excessive urinary oxalate excretion and the overproduction of oxalate, which accumulates in various organs. If left untreated, PHs can cause serious morbidity, end‐stage kidney disease (ESKD), and mortality. Liver transplantation (LT) is a recognized treatment option for children with these diseases. This study aimed to analyze the outcome of PHs disease post‐LT from a single center in Iran.

Methods

This retrospective, single‐center study was conducted at the Shiraz Transplant Center from 2012 to 2023, focusing on liver transplant recipients with PH. We evaluated long‐term outcomes and post‐transplantation results for both deceased donor liver transplantation (DDLT) and living donor liver transplantation (LDLT). Biochemical lab results (pre‐ and post‐transplantation), perioperative data, surgical procedures, transplantation outcomes, and recipient and donor characteristics were reported. Kaplan–Meier survival analysis was used to assess graft and patient survival.

Results

33 recipients with LT (LDLT, n = 6; DDLT, n = 27) were included. The median age at the time of transplantation was 8 years (range: 3–18 years). Following liver transplantation, all of the patients had normalization of liver enzymes. Urine oxalate levels gradually decreased from 198 to 51 (< 45 mg/1.73 m 2 /day). Among the 33 patients, eight experienced episodes of acute rejection, and five developed chronic rejection. Eight patients underwent kidney transplantation before liver transplantation, while 21 patients initially received liver transplantation. 26 patients survived and remained in good health during a median follow‐up period of 7 years (range: 1.5–11 years). For patients with PHs, the survival rates at 6 months, 1 year, 3 years, and 5 years were 100%, 97%, 94%, and 85%, respectively. The graft survival for patients was 100%, 100%, 97%, and 97% at 6 months, 1 year, 3 years, and 5 years, respectively.

Conclusions

PHs is a rare metabolic disorder, and LT significantly improves both survival and quality of life for affected patients. In our cohort, the majority of patients exhibited favorable long‐term outcomes, along with a notable reduction in urine oxalate levels post‐transplantation. However, challenges persist, including graft shortages and the risk of renal graft loss due to oxalosis, which continue to affect overall treatment outcomes. These findings highlight the importance of close monitoring and multidisciplinary care in managing PH patients' post‐transplant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHyperoxaluria, PrimaryHumansChildRetrospective StudiesMaleChild, PreschoolFemaleAdolescentTreatment OutcomeGraft SurvivalIranFollow-Up StudiesLiving Donors

Stichwörter der Autor:innen

graft survivalliver transplantationoutcomeoxalateprimary hyperoxaluria

Autor:innen und Institutionen

  • Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Shiraz Transplant Center, Abu-Ali-Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Pathology, Medical School of Shiraz University, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Zahra Beyzaei, Bita Geramizadeh

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Beyzaei, Z., Shamsaeefar, A., Ghatei, K., Kazemi, K., Nikeghbalian, S., Bahador, A., Dehghani, M., Malekhosseini, S. A., & Geramizadeh, B. (2025). Liver Transplantation in Primary Hyperoxaluria: A Single‐Center 10‐Year Experience. Pediatric Transplantation. https://doi.org/10.1111/petr.70102

Vancouver

Beyzaei Z, Shamsaeefar A, Ghatei K, Kazemi K, Nikeghbalian S, Bahador A, et al. Liver Transplantation in Primary Hyperoxaluria: A Single‐Center 10‐Year Experience. Pediatric Transplantation. 2025. doi:10.1111/petr.70102

BibTeX
@article{Beyzaei2025,
  author = {Beyzaei, Zahra and Shamsaeefar, Alireza and Ghatei, Kiana and Kazemi, Kurosh and Nikeghbalian, Saman and Bahador, Ali and Dehghani, Masoud and Malekhosseini, Seyed-Ali and Geramizadeh, Bita},
  title = {Liver Transplantation in Primary Hyperoxaluria: A Single‐Center 10‐Year Experience},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70102}
}
Kostenlos starten →